These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21045192)

  • 1. Amelioration of murine immune thrombocytopenia by CD44 antibodies: a potential therapy for ITP?
    Crow AR; Song S; Suppa SJ; Ma S; Reilly MP; Andre P; McKenzie SE; Lazarus AH
    Blood; 2011 Jan; 117(3):971-4. PubMed ID: 21045192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of murine passive immune thrombocytopenia by IVIg and a therapeutic monoclonal CD44 antibody does not require the Myd88 signaling pathway.
    Crow AR; Yu H; Han D; Lazarus AH
    PLoS One; 2013; 8(8):e71882. PubMed ID: 23940791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruption.
    Crow AR; Amash A; Lazarus AH
    Transfusion; 2015 Jun; 55(6 Pt 2):1492-500. PubMed ID: 25496771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody-mediated amelioration of murine immune thrombocytopenia.
    Crow AR; Suppa SJ; Chen X; Mott PJ; Lazarus AH
    Blood; 2011 Dec; 118(24):6403-6. PubMed ID: 22001393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG.
    Song S; Crow AR; Freedman J; Lazarus AH
    Blood; 2003 May; 101(9):3708-13. PubMed ID: 12506021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fcγ receptor inhibition.
    Norris PAA; Kaur G; Khan R; Zhu G; Ni H; Lazarus AH
    Blood; 2021 Apr; 137(15):2114-2124. PubMed ID: 33662988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIg.
    Song S; Crow AR; Siragam V; Freedman J; Lazarus AH
    Blood; 2005 Feb; 105(4):1546-8. PubMed ID: 15479722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 antibodies and immune thrombocytopenia in the amelioration of murine inflammatory arthritis.
    Mott PJ; Lazarus AH
    PLoS One; 2013; 8(6):e65805. PubMed ID: 23785450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse background and IVIG dosage are critical in establishing the role of inhibitory Fcγ receptor for the amelioration of experimental ITP.
    Leontyev D; Katsman Y; Branch DR
    Blood; 2012 May; 119(22):5261-4. PubMed ID: 22508937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?
    Siragam V; Brinc D; Crow AR; Song S; Freedman J; Lazarus AH
    J Clin Invest; 2005 Jan; 115(1):155-60. PubMed ID: 15630455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A monoclonal antibody with anti-D-like activity in murine immune thrombocytopenia requires Fc domain function for immune thrombocytopenia ameliorative effects.
    Yu X; Menard M; Seabright G; Crispin M; Lazarus AH
    Transfusion; 2015 Jun; 55(6 Pt 2):1501-11. PubMed ID: 25752470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihuman CD44 antibody BJ18 inhibits platelet phagocytosis by correcting aberrant FcɣR expression and M1 polarization in immune thrombocytopenia.
    Sun L; Li L; Sun T; Zhang L; Li C; Xu M; Hou Y; Peng J; Hou M; Wang L
    Int Immunopharmacol; 2021 Jun; 95():107502. PubMed ID: 33690000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GM-CSF and IL-4 are not involved in IVIG-mediated amelioration of ITP in mice: a role for IL-11 cannot be ruled out.
    Lewis BJB; Leontyev D; Neschadim A; Blacquiere M; Branch DR
    Clin Exp Immunol; 2018 Sep; 193(3):293-301. PubMed ID: 29704458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity.
    Crow AR; Song S; Freedman J; Helgason CD; Humphries RK; Siminovitch KA; Lazarus AH
    Blood; 2003 Jul; 102(2):558-60. PubMed ID: 12649142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIbalpha antibodies.
    Webster ML; Sayeh E; Crow M; Chen P; Nieswandt B; Freedman J; Ni H
    Blood; 2006 Aug; 108(3):943-6. PubMed ID: 16861348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin does not increase FcγRIIB expression levels on monocytes in children with immune thrombocytopenia.
    Shimomura M; Hasegawa S; Seki Y; Fukano R; Hotta N; Ichiyama T
    Clin Exp Immunol; 2012 Jul; 169(1):33-7. PubMed ID: 22670776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells modulate platelet activity in IVIg-mediated amelioration of ITP in mice.
    Huang HS; Sun DS; Lien TS; Chang HH
    Blood; 2010 Dec; 116(23):5002-9. PubMed ID: 20699442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of two high affinity anti-mouse FcRn antibodies: Inhibition of IgG recycling in wild type mice and effect in a mouse model of immune thrombocytopenia.
    Smith B; Christodoulou L; Clargo A; Eddleston A; Greenslade K; Lightwood D; Shock A; Tyson K; Brennan FR
    Int Immunopharmacol; 2019 Jan; 66():362-365. PubMed ID: 30529500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic properties of intravenous immunoglobulin in murine immune thrombocytopenia: support for FcγRIIB falls by the wayside.
    Crow AR; Lazarus AH
    Semin Hematol; 2016 Apr; 53 Suppl 1():S20-2. PubMed ID: 27312158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia.
    Hansen RJ; Balthasar JP
    Blood; 2002 Sep; 100(6):2087-93. PubMed ID: 12200371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.